Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

ADMET—turning chemicals into drugs

Rapidly resolving the pharmacokinetic and toxicological properties of drug candidates remains a key challenge for drug developers.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

© Amy Center

References

  • Lazarou, J., Pomeranz, B.H., & Corey, P.N. Incidence of adverse drug reactions in hospitalised patients. J. Am. Med. Assoc. 279, 1200–1205 (1998).

    Article  CAS  Google Scholar 

  • Lehman Brothers & McKinsey & Co. The Fruits of Genomics. (Lehman Brothers, New York, 2001).

  • Bowen, W.P. et al. Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction. Drug Met. Dis. 28, 781–788 (2000).

    CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hodgson, J. ADMET—turning chemicals into drugs. Nat Biotechnol 19, 722–726 (2001). https://doi.org/10.1038/90761

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/90761

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing